| In vivo imaging of synaptic loss in Alzheimer’s disease with [18F] UCB-H positron emission tomography C Bastin, MA Bahri, F Meyer, M Manard, E Delhaye, A Plenevaux, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 390-402, 2020 | 94 | 2020 |
| Characterization of a temporoparietal junction subtype of Alzheimer's disease F Meyer, M Wehenkel, C Phillips, P Geurts, R Hustinx, C Bernard, ... Human brain mapping 40 (14), 4279-4286, 2019 | 5 | 2019 |
| Neural correlates of impaired cognitive processes underlying self-unawareness in Alzheimer’s disease E Salmon, F Meyer, S Genon, F Collette, C Bastin Cortex, 2023 | 3 | 2023 |
| Dystonia 12: A rare and difficult diagnosis P Leroy, F Meyer, S Vaessen, D Doummar, JP Misson Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie …, 2017 | 2 | 2017 |
| P2‐348: CHARACTERIZATION OF A TEMPOROPARIETAL JUNCTION SUBTYPE OF ALZHEIMER'S DISEASE E Salmon, F Meyer, M Wehenkel, C Phillips, P Geurts, C Bastin Alzheimer's & Dementia 14 (7S_Part_15), P820-P820, 2018 | 1 | 2018 |
| In vivo brainstem tau pathology is related to entorhinal amyloid pathology in middle‐aged healthy participants F Meyer, N Justinas, M Van Egroo, C Dapnée, MA Bahri, K Ekaterina, ... Alzheimer's & Dementia 19, e064891, 2023 | | 2023 |
| Les troubles cognitifs pour le non neurologue F Meyer Back to medical school 2023-Neurologie pour le non neurologue, 2023 | | 2023 |
| PET Pro: An Automated pipeline to estimate the image-derived input function for UCB-H PET S Moallemian, S Dauby, F Meyer, C Bastin, C Phillips, E Salmon, ... INCF 2023, 2023 | | 2023 |
| Treating amyloid in Alzheimer’s disease F Meyer Maîtrise spécialisée en neurologie, 2022 | | 2022 |
| In vivo brainstem tau pathology is related to entorhinal amyloid pathology and basal forebrain amyloid and tau pathology in middle-aged healthy participants F Meyer Alzheimer's Association International Conference, 2022 | | 2022 |
| Pathologies neuromotrices chroniques de l'enfant F DEPIERREUX, F Meyer, L Vogel Journée de formation continue (Centre CINeTique), 2021 | | 2021 |
| La maladie d’Alzheimer à l’ère des biomarqueurs: le point de vue du clinicien F Meyer La maladie d’Alzheimer et son dépistage au laboratoire, 2021 | | 2021 |
| Synaptic Modification in Subjective Cognitive Decline F Meyer Project Presentation, 2020 | | 2020 |
| Higher polygenic risk for insomnia is associated with lower delta power during habitual sleep in young individuals without sleep disorders E Koshmanova, V Muto, M Jaspar, F Meyer, M Grignard, C Berthomier, ... 25th Congress of the European Sleep Research Society (ESRS) 2020, 2020 | | 2020 |
| Adult hippocampus neurogenesis in healthy and Alzheimer subjects F Meyer Datablitz des neurosciences cliniques, 2019 | | 2019 |
| Toward a biological definition of Alzheimer's disease F Meyer Datablitz des neurosciences cliniques-ULiège, 2018 | | 2018 |
| Enseignement postgradue des neurosciences Presentation de cas cliniques par les candidats spécialistes F Meyer Enseignement postgradue des neurosciences Presentation de cas cliniques par …, 2018 | | 2018 |
| Veillissement cognitif: Aspects médicaux F Meyer Cycle de conférences" Vieillissons", 2017 | | 2017 |
| Dystonie de type 12: un diagnostic rare et difficile P Leroy, F Meyer, S Vaessen, D Doummar, JP Misson Archives de Pédiatrie 24 (7), 637-639, 2017 | | 2017 |
| Description et étude d’un nouveau profil d’atteinte métabolique au PET-FDG chez des patients atteints de démence d’Alzheimer probable F Meyer ULiège-Université de Liège, 2017 | | 2017 |
